| Ms Estrevina Rivera, | |
|
1015 Village Dr, Somerset, NJ 08873-4510 | |
| (973) 563-6818 | |
| Not Available |
| Full Name | Ms Estrevina Rivera |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1015 Village Dr, Somerset, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154934271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | 37AC00318900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Estrevina Rivera, 1015 Village Dr, Somerset, NJ 08873-4510 Ph: (973) 563-6818 | Ms Estrevina Rivera, 1015 Village Dr, Somerset, NJ 08873-4510 Ph: (973) 563-6818 |
News Archive
Berkeley HeartLab (BHL), a subsidiary of Celera Corporation, announced today that it has entered into collaborative agreements with Geisinger Medical Center and Proven Diagnostics, a clinical laboratory service recently launched by Geisinger Health System.
Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon's phenylephrine in the United States on an exclusive basis beginning this month.
The future mood swings of people with bipolar disorder can be predicted by their current thoughts and behaviour, a study published today has found.
The Seattle Times/The Orlando Sentinel: "The new catch phrase among homeowners is 'aging in place.' Instead of selling their homes and moving into retirement villages or assisted-living quarters, a growing number of older Americans are modifying their homes to make them more user-friendly as they age. The concept has caught on so successfully, it even has its own National Aging in Place Week, which falls on Oct. 11-16 this year."
Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.
› Verified 7 days ago
Nicole Schlett, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 48 Norma Ave Apt 3c, Somerset, NJ 08873 Phone: 732-599-3188 | |
Judith Velez, MSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 29 Clyde Rd, 201, Somerset, NJ 08873 Phone: 732-873-0736 Fax: 732-873-0736 | |
Danielle Cromartie-williams, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 29 Clyde Rd Ste 201, Somerset, NJ 08873 Phone: 732-429-6239 | |
Mrs. Samantha Hardy, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 225 Demott Ln Ste 203, Somerset, NJ 08873 Phone: 732-873-2777 | |
Ms. Mei-ling Cheng, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12 Bayberry Dr, Somerset, NJ 08873 Phone: 973-763-6982 | |
Mrs. Chrystal Dunkers, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 458 Elizabeth Ave Ste 5-322, Somerset, NJ 08873 Phone: 732-917-7258 Fax: 732-917-7259 |